Business Context and Reporting Period
This Form 8-K Current Report was filed by Sight Sciences, Inc. (SGHT) on July 15, 2022. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the appointment of a director and associated compensation arrangements.
Material Changes
On July 15, 2022, the Board of Directors appointed Tamara Fountain, M.D., as a Class III director. Her term expires at the 2024 annual meeting of stockholders. Dr. Fountain was also appointed to the Nominating and Corporate Governance Committee. There are no related party transactions between the Company and Dr. Fountain.
Compensation and Governance Details
Dr. Fountain's compensation package under the Non-Employee Director Compensation Policy includes:
- Cash Retainers: $40,000 annually for Board service and $5,000 annually for Nominating Committee service, earned quarterly.
- Initial Equity Award: Restricted stock units (RSUs) valued at $240,000 (based on the Reference Price), vesting in equal annual installments over three years.
- Annual Equity Award: Following each annual meeting, RSUs valued at $120,000 (based on the Reference Price), vesting in a single installment on the earlier of the next annual meeting or the first anniversary of the grant date.
Dr. Fountain has also entered into the Company's standard indemnification agreement for directors and officers.
Investor Verification Checklist
- Verify the Reference Price used to calculate the initial and annual RSU grants for Dr. Fountain.
- Confirm the total number of outstanding shares and the impact of the new director equity awards on dilution.
- Review the Company's most recent 10-Q or 10-K for current financial health, as this 8-K contains no financial metrics.
- Check for any subsequent filings regarding the vesting schedule or changes to the Non-Employee Director Compensation Policy.